Herein, we describe the discovery of potent and highly selective inhibitors of both CDK4 and CDK6 via structure-guided optimization of a fragment-based screening hit. CDK6 X-ray crystallography and pharmacokinetic data steered efforts in identifying compound 6, which showed >1000-fold selectivity for CDK4 over CDKs 1 and 2 in an enzymatic assay. Furthermore, 6 demonstrated in vivo inhibition of pRb-phosphorylation and oral efficacy in a Jeko-1 mouse xenograft model.
机构:
Banyu Pharmaceut Co Ltd, Banyu Tsukuba Res Inst, Dept Canc Res, Tsukuba, Ibaraki 3002611, JapanBanyu Pharmaceut Co Ltd, Banyu Tsukuba Res Inst, Dept Canc Res, Tsukuba, Ibaraki 3002611, Japan
Hirai, H
Kawanishi, N
论文数: 0引用数: 0
h-index: 0
机构:
Banyu Pharmaceut Co Ltd, Banyu Tsukuba Res Inst, Dept Canc Res, Tsukuba, Ibaraki 3002611, JapanBanyu Pharmaceut Co Ltd, Banyu Tsukuba Res Inst, Dept Canc Res, Tsukuba, Ibaraki 3002611, Japan
Kawanishi, N
Iwasawa, Y
论文数: 0引用数: 0
h-index: 0
机构:
Banyu Pharmaceut Co Ltd, Banyu Tsukuba Res Inst, Dept Canc Res, Tsukuba, Ibaraki 3002611, JapanBanyu Pharmaceut Co Ltd, Banyu Tsukuba Res Inst, Dept Canc Res, Tsukuba, Ibaraki 3002611, Japan
机构:
Banyu Pharmaceut Co Ltd, Banyu Tsukuba Res Inst, Dept Canc Res, Tsukuba, Ibaraki 3002611, JapanBanyu Pharmaceut Co Ltd, Banyu Tsukuba Res Inst, Dept Canc Res, Tsukuba, Ibaraki 3002611, Japan
Hirai, H
Kawanishi, N
论文数: 0引用数: 0
h-index: 0
机构:
Banyu Pharmaceut Co Ltd, Banyu Tsukuba Res Inst, Dept Canc Res, Tsukuba, Ibaraki 3002611, JapanBanyu Pharmaceut Co Ltd, Banyu Tsukuba Res Inst, Dept Canc Res, Tsukuba, Ibaraki 3002611, Japan
Kawanishi, N
Iwasawa, Y
论文数: 0引用数: 0
h-index: 0
机构:
Banyu Pharmaceut Co Ltd, Banyu Tsukuba Res Inst, Dept Canc Res, Tsukuba, Ibaraki 3002611, JapanBanyu Pharmaceut Co Ltd, Banyu Tsukuba Res Inst, Dept Canc Res, Tsukuba, Ibaraki 3002611, Japan